Alloy Therapeutics, a biotechnology ecosystem firm empowering the worldwide scientific group to make higher medicines collectively, immediately introduced the shut of a USD 75 million Series C financing spherical. The spherical was led by 8VC, Presight Capital, and Peter Thiel with participation from new buyers together with Mubadala Capital, the asset administration arm of Mubadala Investment Company, an unnamed sovereign wealth fund, Founders Fund and Gaingels, in addition to Alloy’s current buyers Luma Bio-IT, Alexandria Venture Investments, and Ulysses Diversified Holdings.
Source link
